Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemoprevention research: implications for primary care practice.

A M Denicoff1, R M Padberg

  • 1National Cancer Institute, 31 Center Drive, Bldg. 31, Room 3A44, Bethesda, MD 20892-2440, USA.

Lippincott'S Primary Care Practice
|March 23, 2001
PubMed
Summary

Cancer prevention research is advancing, identifying agents that reduce cancer incidence in high-risk groups. Primary care providers are key partners in these crucial chemoprevention trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

National efforts to improve the informed consent process.

Seminars in oncology nursing·1999
Same author

Participants strengthen clinical trial research: the vital role of participant advisors in the Breast Cancer Prevention Trial.

Journal of women's health·1997
Same author

Sources of information about consent in cancer research.

Cancer practice·1996
Same author

Phase I crossover study of paclitaxel with r-verapamil in patients with metastatic breast cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1996
Same author

Phase I study of paclitaxel in combination with cyclophosphamide and granulocyte colony-stimulating factor in metastatic breast cancer patients.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1996
Same author

Effect of R-verapamil on the pharmacokinetics of paclitaxel in women with breast cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1995

Area of Science:

  • Oncology
  • Preventive Medicine
  • Clinical Research

Background:

  • Cancer prevention research is expanding, with significant opportunities for impact.
  • Identifying effective agents to reduce cancer incidence in high-risk populations is a key focus.
  • Primary care providers (PCPs) are vital collaborators due to their patient access and commitment to prevention.

Purpose of the Study:

  • To highlight the advancements in cancer prevention research.
  • To inform about the role of PCPs in chemoprevention trials.
  • To provide information on current breast and prostate cancer chemoprevention trials and recruitment.

Main Methods:

  • Overview of the current landscape of cancer prevention research.
  • Discussion on the development and structure of chemoprevention trials.
  • Emphasis on the integration of primary care into national research efforts.

Main Results:

  • Chemoprevention research is identifying agents that significantly reduce cancer incidence.
  • National trials for breast and prostate cancer chemoprevention are actively seeking PCP involvement.
  • PCPs offer unique advantages for patient recruitment and long-term follow-up.

Conclusions:

  • Cancer prevention research offers significant opportunities for reducing disease burden.
  • Primary care settings are essential for the success of large-scale chemoprevention trials.
  • Further information and engagement with PCPs are needed to advance these research efforts.

Related Experiment Videos